TP53 and neoplasm: Molecular studies demonstrate that p53 directly targets the SLC7A11 gene promoter or regulates USP7‐mediated histone H2B mono‐ubiquitination modifications, thereby enhancing tumor cell ferroptosis sensitivity via ALOX12‐dependent mechanisms [452, 453].